Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 5.6305 | 80 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 5.45221 | 78 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 5.4206 | 78 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 4.9109 | 74 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 5.35118 | 78 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 5.42708 | 80 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 5.60994 | 81 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 5.22755 | 77 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 5.03375 | 75 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 5.62245 | 79 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 5.31703 | 78 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 5.40215 | 78 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 5.6836 | 80 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 5.46736 | 79 |